Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	View
CYHB2401621	复方氨基酸注射液（18AA-V-SF）	alanine;Arginine hydrochloride;aspartic acid;cysteine hydrochloride;glutamic acid;glycine;histidine hydrochloride;isoleucine;leucine;Lysine Hydrochloride;Methionone;phenylalanine;proline;serine;threon	Injection	Chemical Drugs(原6)	Supplementary Application	2024-10-11	Hubei Banbantian Pharmaceutical Co Ltd	view
CYHB2401622	复方氨基酸注射液（18AA-V-SF）	alanine;Arginine hydrochloride;aspartic acid;cysteine hydrochloride;glutamic acid;glycine;histidine hydrochloride;isoleucine;leucine;Lysine Hydrochloride;Methionone;phenylalanine;proline;serine;threon	Injection	Chemical Drugs(原6)	Supplementary Application	2024-10-11	Hubei Banbantian Pharmaceutical Co Ltd	view
CYHB2201413	复方氨基酸注射液（18AA-V-SF）	alanine;Arginine hydrochloride;aspartic acid;cysteine hydrochloride;glutamic acid;glycine;histidine hydrochloride;isoleucine;leucine;Lysine Hydrochloride;Methionone;phenylalanine;proline;serine;threon	Injection	Chemical Drugs	Supplementary Application	2022-08-11	Hubei Banbantian Pharmaceutical Co Ltd	view